These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
499 related items for PubMed ID: 376941
1. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats. Salant DJ, Belok S, Stilmant MM, Darby C, Couser WG. Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941 [Abstract] [Full Text] [Related]
2. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. Couser WG, Jermanovich NB, Belok S, Stilmant MM, Hoyer JR. J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884 [Abstract] [Full Text] [Related]
3. Experimental glomerulonephritis in the isolated perfused rat kidney. Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM. J Clin Invest; 1978 Dec; 62(6):1275-87. PubMed ID: 372233 [Abstract] [Full Text] [Related]
4. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats. Bertani T, Remuzzi G, Poggi A, Delaini F, Sacchi G, Morassi L, Verroust P, Mecca G, Donati MB. Clin Exp Immunol; 1983 Jan; 51(1):38-44. PubMed ID: 6339125 [Abstract] [Full Text] [Related]
5. Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein. Couser WG, Stilmant MM, Darby C. Lab Invest; 1976 Jan; 34(1):23-30. PubMed ID: 1246122 [Abstract] [Full Text] [Related]
6. The effects of aminonucleoside of puromycin and nephrotoxic serum on subepithelial immune-deposit formation in passive Heymann nephritis. Couser WG, Salant DJ, Stilmant MM, Arbeit LA, Darby C, Sliogeris VG. J Lab Clin Med; 1979 Dec; 94(6):917-32. PubMed ID: 501213 [No Abstract] [Full Text] [Related]
7. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108. Natori Y, Hayakawa I, Shibata S. Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192 [Abstract] [Full Text] [Related]
8. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. Susani M, Schulze M, Exner M, Kerjaschki D. Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779 [Abstract] [Full Text] [Related]
9. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. Salant DJ, Darby C, Couser WG. J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310 [Abstract] [Full Text] [Related]
10. Pathogenicity of a highly purified brush border membrane preparation in Heymann nephritis. Chant S, Katz A, Silverman M. J Clin Lab Immunol; 1980 Nov; 4(3):133-40. PubMed ID: 6451709 [Abstract] [Full Text] [Related]
12. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat. Weening JJ, Grond J, Hoedemaeker PJ. Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777 [Abstract] [Full Text] [Related]
13. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside. Hoyer JR, Mauer SM, Michael AF. J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713 [Abstract] [Full Text] [Related]
14. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat. Adler S, Baker P, Pritzl P, Couser WG. J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891 [Abstract] [Full Text] [Related]
15. Progressive passive Heymann nephritis in the rat. Barabas AZ, Boyd N, Cornish J, Lannigan R. Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666 [Abstract] [Full Text] [Related]
16. Stimulation of circulating autoantibody levels in the rat with established progressive passive Heymann nephritis. Barabas AZ, Cornish J, Lannigan R. Clin Exp Immunol; 1986 Jul; 65(1):34-41. PubMed ID: 3539426 [Abstract] [Full Text] [Related]
17. Autologous immune complex nephritis in rats. Influence of modification of mononuclear phagocyte system function. Abrass CK. Lab Invest; 1984 Aug; 51(2):162-71. PubMed ID: 6611451 [Abstract] [Full Text] [Related]
18. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease. Camussi G, Noble B, Van Liew J, Brentjens JR, Andres G. J Immunol; 1986 Mar 15; 136(6):2127-35. PubMed ID: 3485141 [Abstract] [Full Text] [Related]
19. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Hara M, Batsford SR, Mihatsch MJ, Bitter-Suermann D, Vogt A. Lab Invest; 1991 Aug 15; 65(2):168-79. PubMed ID: 1881120 [Abstract] [Full Text] [Related]
20. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis. Makker SP, Tramontano A. J Pathol; 2006 Nov 15; 210(3):282-7. PubMed ID: 16981232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]